|
1
|
Gézsi A, Lautner-Csorba O, Erdélyi DJ, Hullám G, Antal P, Semsei ÁF, Kutszegi N, Hegyi M, Csordás K, Kovács G, Szalai C. In interaction with gender a common CYP3A4 polymorphism may influence the survival rate of chemotherapy for childhood acute lymphoblastic leukemia. Pharmacogenomics J 2014; 15:241-7. [PMID: 25266680 DOI: 10.1038/tpj.2014.60] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/04/2014] [Revised: 07/24/2014] [Accepted: 08/21/2014] [Indexed: 11/09/2022]
Abstract
CYP3A4 has an important role in the metabolisms of many drugs used in acute lymphoblastic leukemia (ALL) therapy; still, there are practically no publications about the role of CYP3A4 polymorphisms in ALL pharmacogenomics. We genotyped eight common single-nucleotide polymorphisms (SNPs) in the CYP3A4 and CYP3A5 genes in 511 children with ALL and investigated whether they influenced the survival of the patients. We involved additional 127 SNPs in 34 candidate genes and searched for interactions with respect to the survival rates. Significant association between the survival rates and the common rs2246709 SNP in the CYP3A4 gene was observed. The gender of the patients and the rs1076991 in the MTHFD1 gene strongly influenced this effect. We calculated new risk assessments involving the gender-rs2246709 interaction and showed that they significantly outperformed the earlier risk-group assessments at every time point. If this finding is confirmed in other populations, it can have a considerable prognostic significance.
Collapse
Affiliation(s)
- A Gézsi
- Department of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary
| | - O Lautner-Csorba
- Department of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary
| | - D J Erdélyi
- 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary
| | - G Hullám
- Department of Measurement and Information Systems, University of Technology and Economics, Budapest, Hungary
| | - P Antal
- Department of Measurement and Information Systems, University of Technology and Economics, Budapest, Hungary
| | - Á F Semsei
- Department of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary
| | - N Kutszegi
- Department of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary
| | - M Hegyi
- 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary
| | - K Csordás
- 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary
| | - G Kovács
- 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary
| | - C Szalai
- 1] Department of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary [2] Heim Pal Children Hospital, Budapest, Hungary [3] Csertex Research Laboratory, Budapest, Hungary
| |
Collapse
|
|
2
|
Eipel OT, Németh K, Török D, Csordás K, Hegyi M, Ponyi A, Ferenczy A, Erdélyi DJ, Csóka M, Kovács GT. The glucocorticoid receptor gene polymorphism N363S predisposes to more severe toxic side effects during pediatric acute lymphoblastic leukemia (ALL) therapy. Int J Hematol 2013; 97:216-22. [DOI: 10.1007/s12185-012-1236-1] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2012] [Revised: 11/28/2012] [Accepted: 11/28/2012] [Indexed: 11/27/2022]
|